262 related articles for article (PubMed ID: 34418108)
21. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
22. Value of T
Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
[TBL] [Abstract][Full Text] [Related]
23. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
[TBL] [Abstract][Full Text] [Related]
26. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer.
Qiu Y; Liu YF; Shu X; Qiao XF; Ai GY; He XJ
Acad Radiol; 2023 Sep; 30 Suppl 1():S1-S13. PubMed ID: 37393175
[TBL] [Abstract][Full Text] [Related]
27. Utility of T
Nketiah GA; Elschot M; Scheenen TW; Maas MC; Bathen TF; Selnæs KM;
Sci Rep; 2021 Jan; 11(1):2085. PubMed ID: 33483545
[TBL] [Abstract][Full Text] [Related]
28. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
30. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
31. Co-trained convolutional neural networks for automated detection of prostate cancer in multi-parametric MRI.
Yang X; Liu C; Wang Z; Yang J; Min HL; Wang L; Cheng KT
Med Image Anal; 2017 Dec; 42():212-227. PubMed ID: 28850876
[TBL] [Abstract][Full Text] [Related]
32. Comparison of mono-exponential, bi-exponential, kurtosis, and fractional-order calculus models of diffusion-weighted imaging in characterizing prostate lesions in transition zone.
Liu G; Lu Y; Dai Y; Xue K; Yi Y; Xu J; Wu D; Wu G
Abdom Radiol (NY); 2021 Jun; 46(6):2740-2750. PubMed ID: 33388809
[TBL] [Abstract][Full Text] [Related]
33. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.
Chatterjee A; Gallan AJ; He D; Fan X; Mustafi D; Yousuf A; Antic T; Karczmar GS; Oto A
Abdom Radiol (NY); 2019 Jun; 44(6):2233-2243. PubMed ID: 30955071
[TBL] [Abstract][Full Text] [Related]
34. Fully automated quantification of in vivo viscoelasticity of prostate zones using magnetic resonance elastography with Dense U-net segmentation.
Aldoj N; Biavati F; Dewey M; Hennemuth A; Asbach P; Sack I
Sci Rep; 2022 Feb; 12(1):2001. PubMed ID: 35132102
[TBL] [Abstract][Full Text] [Related]
35. Automated prostate multi-regional segmentation in magnetic resonance using fully convolutional neural networks.
Jimenez-Pastor A; Lopez-Gonzalez R; Fos-Guarinos B; Garcia-Castro F; Wittenberg M; Torregrosa-Andrés A; Marti-Bonmati L; Garcia-Fontes M; Duarte P; Gambini JP; Bittencourt LK; Kitamura FC; Venugopal VK; Mahajan V; Ros P; Soria-Olivas E; Alberich-Bayarri A
Eur Radiol; 2023 Jul; 33(7):5087-5096. PubMed ID: 36690774
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
37. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
38. Automated prostate cancer detection using T2-weighted and high-b-value diffusion-weighted magnetic resonance imaging.
Kwak JT; Xu S; Wood BJ; Turkbey B; Choyke PL; Pinto PA; Wang S; Summers RM
Med Phys; 2015 May; 42(5):2368-78. PubMed ID: 25979032
[TBL] [Abstract][Full Text] [Related]
39. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
Aldoj N; Lukas S; Dewey M; Penzkofer T
Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
[TBL] [Abstract][Full Text] [Related]
40. The added value of PSMA PET/MR radiomics for prostate cancer staging.
Solari EL; Gafita A; Schachoff S; Bogdanović B; Villagrán Asiares A; Amiel T; Hui W; Rauscher I; Visvikis D; Maurer T; Schwamborn K; Mustafa M; Weber W; Navab N; Eiber M; Hatt M; Nekolla SG
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):527-538. PubMed ID: 34255130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
